BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28859074)

  • 1. Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.
    Britton E; Rogerson C; Mehta S; Li Y; Li X; ; Fitzgerald RC; Ang YS; Sharrocks AD
    PLoS Genet; 2017 Aug; 13(8):e1006879. PubMed ID: 28859074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
    Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
    Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.
    Chen L; Huang M; Plummer J; Pan J; Jiang YY; Yang Q; Silva TC; Gull N; Chen S; Ding LW; An O; Yang H; Cheng Y; Said JW; Doan N; Dinjens WN; Waters KM; Tuli R; Gayther SA; Klempner SJ; Berman BP; Meltzer SJ; Lin DC; Koeffler HP
    Gut; 2020 Apr; 69(4):630-640. PubMed ID: 31409603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.
    Keld R; Guo B; Downey P; Gulmann C; Ang YS; Sharrocks AD
    Mol Cancer; 2010 Dec; 9():313. PubMed ID: 21143918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma.
    Ma S; Zhou B; Yang Q; Pan Y; Yang W; Freedland SJ; Ding LW; Freeman MR; Breunig JJ; Bhowmick NA; Pan J; Koeffler HP; Lin DC
    Cancer Res; 2021 Mar; 81(5):1216-1229. PubMed ID: 33402390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma.
    Rogerson C; Ogden S; Britton E; ; Ang Y; Sharrocks AD
    Elife; 2020 Sep; 9():. PubMed ID: 32880368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression.
    Alder D; Braun M; Nikolov P; Boehm D; Scheble V; Menon R; Fend F; Kristiansen G; Perner S; Wernert N
    Hum Pathol; 2012 Nov; 43(11):1910-6. PubMed ID: 22569213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY; Yu T; Huang Y; Cui L; Hong W
    J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
    Oh S; Shin S; Janknecht R
    Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
    Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
    Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of the FOXM1 target gene network and its coregulatory partners in oesophageal adenocarcinoma.
    Wiseman EF; Chen X; Han N; Webber A; Ji Z; Sharrocks AD; Ang YS
    Mol Cancer; 2015 Mar; 14():69. PubMed ID: 25889361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development.
    Watts JA; Zhang C; Klein-Szanto AJ; Kormish JD; Fu J; Zhang MQ; Zaret KS
    PLoS Genet; 2011 Sep; 7(9):e1002277. PubMed ID: 21935353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
    Zhang M; Maass N; Magit D; Sager R
    Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
    Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
    Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.
    Lin DC; Dinh HQ; Xie JJ; Mayakonda A; Silva TC; Jiang YY; Ding LW; He JZ; Xu XE; Hao JJ; Wang MR; Li C; Xu LY; Li EM; Berman BP; Phillip Koeffler H
    Gut; 2018 Oct; 67(10):1769-1779. PubMed ID: 28860350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways.
    Ahmed I; Yang SH; Ogden S; Zhang W; Li Y; ; Sharrocks AD
    Elife; 2023 Feb; 12():. PubMed ID: 36803948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.